Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)...
Use this information to figure out if this company is an ideal customer for you.
11 - 50 Employees
$50M - $100M
linkedin.com/company/madrigal-pharmaceuticals-inc-
Madrigal Pharmaceuticals’s CEO is Bill Sibold
Madrigal Pharmaceuticals’s CMO is Rebecca Taub
Madrigal Pharmaceuticals’s CFO is Alex Howarth
Madrigal Pharmaceuticals’s phone number is 2675131789
Madrigal Pharmaceuticals’s official website is madrigalpharma.com
Madrigal Pharmaceuticals’s revenue is $50M - $100M
Madrigal Pharmaceuticals has 11 - 50 employees
Madrigal Pharmaceuticals is in the industry of: Pharmaceuticals
